Literature DB >> 628081

The extent and character of drug consumption during pregnancy.

P L Doering, R B Stewart.   

Abstract

One hundred sixty-eight obstetrical patients' conditions were monitored prospectively throughout the prenatal, perinatal, and postpartum periods to obtain data on maternal drug consumption. In the prenatal period, all patients received at least two different drug products: 93.4% received five or more, while one patient reported taking 32 different products. The average number of drug products used in the prenatal period was 11.0. The mean perinatal exposure in patients undergoing vaginal delivery was 7.0. Analysis by therapeutic category was performed. Information gathered confirms the fact that pregnant women do take a large number of different types of medications, the consequences of which remain unknown.

Entities:  

Mesh:

Year:  1978        PMID: 628081

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  10 in total

1.  [Not Available].

Authors:  C Ménard
Journal:  Can Fam Physician       Date:  1979-06       Impact factor: 3.275

2.  Post natal use of analgesics: comparisons between conventional postnatal wards and a maternity hotel.

Authors:  Hedvig Nordeng; Anne Eskild; Britt-Ingjerd Nesheim
Journal:  Pharm World Sci       Date:  2010-02-10

3.  Drug use in pregnancy: an overview of epidemiological (drug utilization) studies.

Authors:  M Bonati; R Bortolus; F Marchetti; M Romero; G Tognoni
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Antibiotics in pregnancy: toxicity and teratogenicity.

Authors:  H Knothe; G A Dette
Journal:  Infection       Date:  1985 Mar-Apr       Impact factor: 3.553

5.  Information on drug use in pregnancy from the Viewpoint Regional Drug Information Centre.

Authors:  O Kasilo; M Romero; M Bonati; G Tognoni
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 6.  Cephalosporins in urinary tract infection.

Authors:  L O Gentry
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Impact of physician counseling and perception of teratogenic risks: a survey of 96 nonpregnant women with anxiety.

Authors:  Tiffany Behringer; Bruce L Rollman; Bea Herbeck-Belnap; Patricia R Houck; Sati Mazumdar; Eleanor Bimla Schwarz
Journal:  Prim Care Companion CNS Disord       Date:  2011

Review 8.  Use of benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations.

Authors:  J H Kanto
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

Review 9.  Non-narcotic analgesics. Use in pregnancy and fetal and perinatal effects.

Authors:  M A Heymann
Journal:  Drugs       Date:  1986       Impact factor: 9.546

10.  Use of psychotropic drugs during pregnancy. A report of the international co-operative drug use in pregnancy (DUP) study. Collaborative Group on Drug Use in Pregnancy (CGDUP).

Authors:  F Marchetti; M Romero; M Bonati; G Tognoni
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.